Induction Healthcare Group Stock Working Capital

INHC Stock   6.00  0.50  7.69%   
Induction Healthcare Group fundamentals help investors to digest information that contributes to Induction Healthcare's financial success or failures. It also enables traders to predict the movement of Induction Stock. The fundamental analysis module provides a way to measure Induction Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Induction Healthcare stock.
Short Long Term Debt TotalTotal Assets29.8M
Net Working Capital is likely to drop to about 4.4 M in 2025. Change In Working Capital is likely to gain to about (691.6 K) in 2025.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Induction Healthcare Group Company Working Capital Analysis

Induction Healthcare's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .

Working Capital

 = 

Current Assets

-

Current Liabilities

More About Working Capital | All Equity Analysis

Current Induction Healthcare Working Capital

    
  5.2 M  
Most of Induction Healthcare's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Induction Healthcare Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
Competition

Induction Net Invested Capital

Net Invested Capital

21.21 Million

12.416.542.324.320.423.421.232%157%-43%-16%15%-9%100%
At this time, Induction Healthcare's Net Invested Capital is comparatively stable compared to the past year.
According to the company's disclosures, Induction Healthcare Group has a Working Capital of 5.2 M. This is 98.78% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The working capital for all United Kingdom stocks is 99.65% higher than that of the company.

Induction Working Capital Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Induction Healthcare's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Induction Healthcare could also be used in its relative valuation, which is a method of valuing Induction Healthcare by comparing valuation metrics of similar companies.
100%
Induction Healthcare is currently under evaluation in working capital category among its peers.

Induction Fundamentals

Return On Equity-0.17
Return On Asset-0.1
Profit Margin(0.31) %
Operating Margin(0.62) %
Current Valuation2 M
Shares Outstanding93.85 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31100%200%300%400%500%600%700%
Shares Owned By Insiders52.70 %
Shares Owned By Institutions43.44 %
Price To Book0.31 X
Price To Sales0.44 X
Revenue13.65 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312,000%4,000%6,000%8,000%10,000%12,000%
Gross Profit10.21 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-15,000%-10,000%-5,000%0%
EBITDA(165 K)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%0%100%200%300%
Net Income(3.26 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31100%200%300%400%500%
Total Debt57 K
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-80%-60%-40%-20%
Book Value Per Share0.19 X
Cash Flow From Operations(1.09 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-40%-20%0%20%40%60%80%
Earnings Per Share(0.03) X
Target Price21.0
Number Of Employees74
Beta-0.55
Market Capitalization5.63 M
Total Asset33.37 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312,000%4,000%6,000%8,000%
Retained Earnings(42.73 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%500%1,000%1,500%
Working Capital5.2 M
Net Asset33.37 M

About Induction Healthcare Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Induction Healthcare Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Induction Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Induction Healthcare Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Induction Stock Analysis

When running Induction Healthcare's price analysis, check to measure Induction Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Induction Healthcare is operating at the current time. Most of Induction Healthcare's value examination focuses on studying past and present price action to predict the probability of Induction Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Induction Healthcare's price. Additionally, you may evaluate how the addition of Induction Healthcare to your portfolios can decrease your overall portfolio volatility.